Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marquette, K.
Right arrow Articles by Kaufman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marquette, K.
Right arrow Articles by Kaufman, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain

KA Marquette, DD Pittman and RJ Kaufman

Genetics Institute, Cambridge, MA, USA.

Blood coagulation factors V and VIII are homologous proteins that have the domain organization A1-A2-B-A3-C1-C2. Upon thrombin activation, the B-domains of both molecules are released. Previous studies on factor VIII showed that the B-domain was not required for thrombin cleavage or activity. In contrast, deletion of the factor V B-domain (residues 709 to 1545) yielded a molecule with sevenfold reduced procoagulant activity that was not cleaved by thrombin. However, this factor V B- domain deletion molecule was activated by factor Xa, although the fold- activation was 85% that of wild-type factor V. Thrombin cleavage of factor V occurs initially after residue 709 and subsequently after residues 1018 and 1545. The requirement for thrombin cleavage within the B-domain at residue 1018 was evaluated by mutagenesis of Arg1018 to Ile. In the resultant R1018I mutant, the rate of thrombin activation and appearance of maximal cofactor activity was delayed and was consistent with delayed cleavage of the light chain at residue 1545. In contrast, the rate of factor Xa activation in the R1018I mutant was not altered. This finding suggests that thrombin cleavage at 1018 facilitates subsequent thrombin cleavage at 1545. Further mutagenesis was used to study the requirement for sequences within the factor V B- domain for thrombin cleavage at residue 1545. Whereas the factor V deletion molecule removing residues 709 to 1545 was not cleaved by thrombin, a smaller B-domain deletion molecule (residues 709 to 1476) containing an acidic amino acid-rich region (residues 1490 to 1520) was effectively cleaved by thrombin. These results show that residues 1476 to 1545, which contain an acidic amino acid-rich region, were required for thrombin cleavage of the light chain. Introduction of an acidic amino acid-rich region from factor VIII (residues 337 to 372) into the factor V 709 to 1545 deletion also restored thrombin cleavage of the light chain. In contrast, similar replacement with the acidic region from the factor VIII light chain (residues 1649 to 1689) was significantly less effective in promoting thrombin cleavage of the light chain. This finding suggests that the different acidic regions in factors V and VIII are not functionally equivalent in their interaction with thrombin.(ABSTRACT TRUNCATED AT 400 WORDS)

Volume 86, Issue 8, pp. 3026-3034, 10/15/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Segers, B. Dahlback, P. E. Bock, G. Tans, J. Rosing, and G. A. F. Nicolaes
The Role of Thrombin Exosites I and II in the Activation of Human Coagulation Factor V
J. Biol. Chem., November 23, 2007; 282(47): 33915 - 33924.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Zhu, R. Toso, and R. M. Camire
Inhibitory Sequences within the B-domain Stabilize Circulating Factor V in an Inactive State
J. Biol. Chem., May 18, 2007; 282(20): 15033 - 15039.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Bukys, T. Orban, P. Y. Kim, D. O. Beck, M. E. Nesheim, and M. Kalafatis
The Structural Integrity of Anion Binding Exosite I of Thrombin Is Required and Sufficient for Timely Cleavage and Activation of Factor V and Factor VIII
J. Biol. Chem., July 7, 2006; 281(27): 18569 - 18580.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Toso and R. M. Camire
Removal of B-domain Sequences from Factor V Rather than Specific Proteolysis Underlies the Mechanism by Which Cofactor Function Is Realized
J. Biol. Chem., May 14, 2004; 279(20): 21643 - 21650.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. O. Beck, M. A. Bukys, L. S. Singh, K. A. Szabo, and M. Kalafatis
The Contribution of Amino Acid Region Asp695-Tyr698 of Factor V to Procofactor Activation and Factor Va Function
J. Biol. Chem., January 23, 2004; 279(4): 3084 - 3095.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. S. Rao, S. Swarup, and R. M. Kini
The nonenzymatic subunit of pseutarin C, a prothrombin activator from eastern brown snake (Pseudonaja textilis) venom, shows structural similarity to mammalian coagulation factor V
Blood, August 15, 2003; 102(4): 1347 - 1354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Steen and B. Dahlback
Thrombin-mediated Proteolysis of Factor V Resulting in Gradual B-domain Release and Exposure of the Factor Xa-binding Site
J. Biol. Chem., October 4, 2002; 277(41): 38424 - 38430.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. R. Dharmawardana, S. T. Olson, and P. E. Bock
Role of Regulatory Exosite I in Binding of Thrombin to Human Factor V, Factor Va, Factor Va Subunits, and Activation Fragments
J. Biol. Chem., June 25, 1999; 274(26): 18635 - 18643.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Thorelli, R. J. Kaufman, and B. Dahlback
Cleavage of Factor V at Arg 506 by Activated Protein C and the Expression of Anticoagulant Activity of Factor V
Blood, April 15, 1999; 93(8): 2552 - 2558.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Thorelli, R. J. Kaufman, and B. Dahlback
The C-terminal Region of the Factor V B-domain Is Crucial for the Anticoagulant Activity of Factor V
J. Biol. Chem., June 26, 1998; 273(26): 16140 - 16145.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. L. Yang, J. Cui, A. Rehumtulla, A. Yang, M. Moussalli, R. J. Kaufman, and D. Ginsburg
The Structure and Function of Murine Factor V and Its Inactivation by Protein C
Blood, June 15, 1998; 91(12): 4593 - 4599.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020